VOLUME 63   2002   SUPPLEMENT 2

ARTICLES

3 Unmet Need: What Justifies the Search for a New Antidepressant? John F. Greden
[Abstract] [PDF]

8 Factors Contributing to Failed Trials of New Agents: Can Technology Prevent Some Problems? John H. Greist, James C. Mundt, and Kenneth Kobak
[Abstract] [PDF]

14 Can Monoamine-Based Therapies Be Improved? Mark A. Demitrack
[Abstract] [PDF]

19 Beyond Monoamine-Based Therapies: Clues to New Approaches. Phil Skolnick
[Abstract] [PDF]

24 Commentary. Studying New Antidepressants: If There Were a Light at the End of the Tunnel, Could We See It? Michael E. Thase
[PDF]